Variant report
Variant | nsv1029047 |
---|---|
Chromosome Location | chr8:5950611-5966081 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANGPT2-3 | chr8:5957850-5957973 | ENSG00000253880 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141277132 | chr8:5952602-5952603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575480630 | chr8:5952609-5952610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10503353 | chr8:5952616-5952617 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs561460142 | chr8:5952621-5952622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528848793 | chr8:5952625-5952626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548727960 | chr8:5952658-5952659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188845474 | chr8:5952662-5952663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528207696 | chr8:5952667-5952668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551544963 | chr8:5952669-5952670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146928331 | chr8:5952707-5952708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181690742 | chr8:5952722-5952723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550815056 | chr8:5952730-5952731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560926676 | chr8:5952732-5952733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574379641 | chr8:5952737-5952738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536600625 | chr8:5952764-5952765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373560319 | chr8:5952770-5952771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553101318 | chr8:5952772-5952773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149272646 | chr8:5952776-5952777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs17076021 | chr8:5952805-5952806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs137940899 | chr8:5952809-5952810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577751225 | chr8:5952823-5952824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13268498 | chr8:5952834-5952835 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs76271383 | chr8:5952860-5952861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555217923 | chr8:5952864-5952865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs62494445 | chr8:5952885-5952886 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs542572066 | chr8:5952889-5952890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559078959 | chr8:5952908-5952909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528118154 | chr8:5952914-5952915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs111933595 | chr8:5952941-5952942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10503354 | chr8:5952944-5952945 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs546029541 | chr8:5952947-5952948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550504278 | chr8:5952991-5952992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141563397 | chr8:5953006-5953007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529937368 | chr8:5953015-5953016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527770010 | chr8:5953023-5953024 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547602091 | chr8:5953037-5953038 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375184538 | chr8:5953039-5953040 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558237258 | chr8:5953042-5953043 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536217261 | chr8:5953056-5953057 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs190213997 | chr8:5953094-5953095 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558593813 | chr8:5953123-5953124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182417932 | chr8:5953133-5953134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547490326 | chr8:5953147-5953148 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185854081 | chr8:5953167-5953168 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76175337 | chr8:5953231-5953232 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs377682101 | chr8:5953234-5953235 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs575020851 | chr8:5953238-5953239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540545707 | chr8:5953241-5953242 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554536750 | chr8:5953244-5953245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572840327 | chr8:5953248-5953249 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5952600-5953000 | Enhancers | Fetal Brain Female | brain |
2 | chr8:5952800-5954400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr8:5953000-5954000 | Weak transcription | Fetal Brain Female | brain |
4 | chr8:5953400-5954200 | Enhancers | Brain Substantia Nigra | brain |
5 | chr8:5953600-5954000 | Enhancers | Brain Cingulate Gyrus | brain |
6 | chr8:5954000-5954200 | Enhancers | Fetal Brain Male | brain |
7 | chr8:5954200-5954400 | Enhancers | Fetal Brain Female | brain |
8 | chr8:5954200-5955400 | Weak transcription | Fetal Brain Male | brain |
9 | chr8:5962200-5979000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |